cantly higher than the cutoff value of 85 cm (p＜ 0.01). However, it should be noted that not all subjects had a waist circumference ≥ 85 cm, as shown in Fig. 1A . Indeed, the prevalence of a normal waist circumference (i.e., ＜85 cm) was as high as 34% (n = 102 of 303) in the subjects. Fig. 1B shows the prevalence of a normal waist circumference in the subgroups classified by accumulated metabolic abnormalities.
On the other hand, the waist circumference of women (n = 42) was 86±12 cm (Fig. 1C) , and the average value was in turn significantly lower than the cutoff value of 90 cm (p＜0.05). Furthermore, as shown in Fig. 1D , the prevalence of a normal waist circumference (i.e., ＜90 cm) was as high as 71% (n = 30 of 42), indicating that the majority lacked abdominal obesity. When the prevalence of those with three or more metabolic abnormalities without abdominal obesity was assessed in the whole population, it was similar between men and women: 5% (n = 102 of 2175) in men and 4% (n = 30 of 759) in women (p = 0.48).
To our best knowledge, this is the first report revealing the prevalence of a normal waist circumference in Japanese subjects with overlapping metabolic abnormalities who could be diagnosed with metabolic syndrome according to the international criteria 1) . The criteria were published years ago but are still discussed from many aspects [3] [4] [5] . Treating abdominal obesity as a selectable component is one of the topics 5) . Metabolic syndrome diagnosed by the criteria can include overlapping metabolic abnormalities unrelated to abdominal adiposity. If the prevalence of these cases is very low and clinically ignorable, the emphasis on these "rare exceptions" might not always be necessary in healthcare settings; however, our study revealed that the lack of abdominal obesity was rather common in subjects with sufficient metabolic abnormalities to be diagnosed with metabolic syndrome. Around onethird of the men and two-thirds of the women lacked an increased waist circumference.
It is well known that clustering metabolic abnormalities are independent risk factors of atherosclerosis irrespective of the presence of abdominal obesity 6, 7) , and therefore their management is clinically important. In the subjects with accumulated metabolic abnormalities who have abdominal obesity, a strategy targeting visceral fat reduction is important 5) . On the other hand, such a strategy is not useful in subjects
To the Editor
Recently, international diagnostic criteria of metabolic syndrome were jointly proposed by the International Diabetes Federation and the American Heart Association/National Heart, Lung, and Blood Institute 1) . In the criteria, increased waist circumference, i.e., abdominal obesity, is not treated as an obligatory component, but as an equal component to other metabolic abnormalities. This is in contrast to the original diagnostic criteria in Japan 2) , in which abdominal obesity is a key and obligatory component of metabolic syndrome. The international criteria mean that some subjects diagnosed with metabolic syndrome may have metabolic abnormalities without abdominal obesity, suggesting that their overlapped metabolic abnormalities are not based on abdominal obesity.
To date, there are no data available about the prevalence of these cases, especially in Asia. We therefore investigated waist circumference in Japanese subjects who could be diagnosed with metabolic syndrome by the international criteria due to the coexistence of three or more metabolic abnormalities.
We used the database of Japanese employees of Amagasaki City Office who participated in an annual health checkup (UMIN000002391). Of the 2175 men and 759 women attending the health checkup in fasting state, whose age was 47±11 years, 303 men and 42 women (14% and 6%, respectively: p＜0.01) had three or more components other than increased waist circumference (i.e., hypertriglyceridemia, decreased HDL cholesterol level, raised blood pressure, and/or elevated fasting glucose level) and could be diagnosed with metabolic syndrome, irrespective of abdominal obesity, according to the international criteria 1)
. They accounted for 58% and 71% of male and female cases with metabolic syndrome. In the male subjects with three or more metabolic abnormalities, the prevalence of hypertriglyceridemia, decreased HDL cholesterol level, raised blood pressure and elevated fasting glucose level was 97% (n= 293), 61% (n= 186), 91% (n = 275), and 81% (n = 254), respectively. The corresponding prevalence in women was 86% (n = 36), 81% (n = 34), 81% (n = 34), and 71% (n = 30), respectively. We analyzed the waist circumference in these subjects.
As a result, the waist circumference of men (n = 303) was 89±9 cm, and the average value was signifi-reported its fairly good correlation with visceral fat deposits measured by computed tomography (CT) 8) , and its high reproducibility 9) . Second, we used the data of city employees and some may wonder how representative the current population is of the target population in Japan. However, given that cohorts of civil servants are often used as those providing representative features overseas 10) , we believe that the current study design could provide reliable information to some extent.
In conclusion, in Japanese employees with three or more metabolic abnormalities who could be diagnosed with metabolic syndrome by the international criteria, not a few subjects lacked increased waist circumference.
with metabolic abnormalities but without abdominal obesity. In these cases, visceral fat accumulation does not seem to be the origin of their accumulated metabolic abnormalities. Given the current findings that considerable subjects were free from abdominal obesity despite their accumulated metabolic abnormalities, it would be worth emphasizing in healthcare practice that metabolic syndrome diagnosed by the international criteria is composed of different pathogeneses requiring different management strategies.
The current study had some limitations. First, we evaluated visceral fat accumulation only with waist circumference. However, waist circumference is a crude but relevant index of visceral fat deposits and is now widely used in clinical practice. Previous studies 
